SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3.15 Cr | ₹7.92 Cr | ₹-5.20 Cr | ₹3.17 Cr | ₹7.99 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3.15 Cr |
| Mar2025 | ₹7.92 Cr |
| Mar2024 | ₹-5.20 Cr |
| Mar2023 | ₹3.17 Cr |
| Mar2022 | ₹7.99 Cr |
How is Cash Flow from Operating Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.15 Cr | -60.23 | |
| Mar2025 | ₹7.92 Cr | Positive | |
| Mar2024 | ₹-5.20 Cr | Negative | |
| Mar2023 | ₹3.17 Cr | -60.32 | |
| Mar2022 | ₹7.99 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹3,606.8 Cr | NA | 16.8% | 94.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | NA |
16.8% |
94.9% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses